Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats

Código QR

Reduction of lns-1 gene expression and tissue insulin levels in n5-STZ rats

Objective: The high global incidence of type 2 diabetes has challenged researchers to establish animal models that resemble the chronic stage observed in type 2 diabetes patients. One such model is induced by neonatal streptozotocin (n-STZ) administration to rat pups at 0, 2, or 5 days after birth....

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Vargas Guerrero,Belinda, García López,Pedro M, González Santiago,Ana E, Domínguez Rosales,José A, Gurrola Díaz,Carmen M
Lenguaje:	English
Publicado:	Sociedad de Biología de Chile 2013
Materias:	chronic hyperglycemia in vivo diabetes models lns-1 gene type 2 diabetes
Acceso en línea:	http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602013000300009
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Cetoacidosis diabética euglicémica asociada a inhibidor de cotransportador de sodio glucosa Tipo 2 en paciente con diabetes Mellitus Tipo 1
por: Novik A,Victoria, et al.
Publicado: (2017)

PROGRESSIVE EFFECTS OF DIABETES MELLITUS ON THE SKIN EPITHELIUM OF THE RA
por: Benetti Tanga,Marcelo, et al.
Publicado: (2003)

Frequency of Diabetic Ketoacidosis and Severe Hypoglycemia in Children with Type 1 Diabetes
por: A Homaei, et al.
Publicado: (2022)

Cyclophilin A (CyPA) as a Novel Biomarker for Early Detection of Diabetic Nephropathy in an Animal Model
por: El-Ebidi AM, et al.
Publicado: (2020)

Novel Triterpenoids from <i>Cassia fistula</i> Stem Bark Depreciates STZ-Induced Detrimental Changes in IRS-1/Akt-Mediated Insulin Signaling Mechanisms in Type-1 Diabetic Rats
por: Sabapathy Indu, et al.
Publicado: (2021)

Control glicémico de pacientes diabéticos hospitalizados en un Servicio de Medicina Interna
por: Solís,Iván, et al.
Publicado: (2012)

Efficacious and safe control of glycemia using Apidra insulin
por: Elena Valer'evna Biryukova, et al.
Publicado: (2010)

Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus
por: Vladimir V. Salukhov, et al.
Publicado: (2016)

Repression of Ppargcla Gene in Liver of Hyperglycemic Rats Induced with High Fat Diet Combined with Streptozotocin
por: Hernández,Alfonso, et al.
Publicado: (2012)

The Insulin-Sensitizer Pioglitazone Remodels Adipose Tissue Phospholipids in Humans
por: Juan P. Palavicini, et al.
Publicado: (2021)

The Application of Exercise Training for Diabetic Peripheral Neuropathy
por: Clifton J. Holmes, et al.
Publicado: (2021)

Molecular and morphological peculiarities of chronic placental insufficiency formation caused by different types of diabetes mellitus
por: Tatyana G. Tral, et al.
Publicado: (2020)

Historia natural de retinopatía diabética en un estudio a largo plazo en pacientes con diabetes tipo 1. Factores de riesgo para progresión a enfermedad proliferante
por: Verdaguer,Juan, et al.
Publicado: (2009)

Insulin is secreted upon glucose stimulation by both gastrointestinal enteroendocrine K-cells and L-cells engineered with the preproinsulin gene
por: Encina,Gonzalo, et al.
Publicado: (2011)

Clinical and pathogenetic features of lesions of the lower extremities in patients with type 2 diabetes mellitus and chronic venous insufficiency
por: Anna A. Shlyakova, et al.
Publicado: (2016)

Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016
por: Tripathy JP
Publicado: (2018)

Perspectives on reducing mortality attributed to acute myocardial infarction among patients with type 2 diabetes mellitus in multicenter randomized trials
por: Sergey V. Kakorin, et al.
Publicado: (2016)

Association of single nucleotide polymorphisms with insulin secretion, insulin sensitivity, and diabetes in women with a history of gestational diabetes mellitus
por: Rashmi B. Prasad, et al.
Publicado: (2021)

Diabetic retinopathy. Results of international multicentre studies
por: Olga Mikhailovna Smirnova
Publicado: (2010)

Micro-RNA Implications in Type-1 Diabetes Mellitus: A Review of Literature
por: Kosmas Margaritis, et al.
Publicado: (2021)

Evaluation of the Effect of an Aqueous Extract of Azadirachta indica (Neem) Leaves and Twigs on Glycemic Control, Endothelial Dysfunction and Systemic Inflammation in Subjects with Type 2 Diabetes Mellitus – A Randomized, Double-Blind, Placebo-Controlled Clinical Study
por: Pingali U, et al.
Publicado: (2020)

Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes
por: Bouldjennet F, et al.
Publicado: (2020)

Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
por: Pollock RF, et al.
Publicado: (2018)

The polypharmacy reduction potential of cinnamic acids and some related compounds in pre- and post-onset management of type 2 diabetes mellitus
por: Barre Douglas Edward, et al.
Publicado: (2020)

Antidiabetic and Nephroprotective Effects of Polysaccharide Extract from the Seaweed Caulerpa racemosa in High Fructose-Streptozotocin Induced Diabetic Nephropathy
por: Cao M, et al.
Publicado: (2021)

Effect of Phytopreparations Based on Bioreactor-Grown Cell Biomass of <i>Dioscorea deltoidea</i>, <i>Tribulus terrestris</i> and <i>Panax japonicus</i> on Carbohydrate and Lipid Metabolism in Type 2 Diabetes Mellitus
por: Maria N. Povydysh, et al.
Publicado: (2021)

Cuadro clínico de inicio de la diabetes tipo 1 en el niño
por: Hodgson B,María Isabel, et al.
Publicado: (2006)

1,5-anhydroglucitol in diabetes: its role in diagnostics, screening, glycemic status assessment, and the prediction of complications
por: V. V. Klimontov, et al.
Publicado: (2020)

Platelet Mediated Inflammation in Coronary Artery Disease with Type 2 Diabetes Patients
por: Johny E, et al.
Publicado: (2021)

Retrospective trial of long acting analogues detemir and degludec usage in children and adolescents to overcome glucose variability caused by dawn phenomenon and reverse dawn phenomenon
por: A. V. Vitebskaya, et al.
Publicado: (2021)

Antihyperglycemic activity of Centella asiatica (L.) Urb. leaf ethanol extract SNEDDS in zebrafish (Danio rerio)
por: Hayati Farida, et al.
Publicado: (2021)

The level of glycemia as a risk factor of cardiovascular diseases
por: Ashot Musaelovich Mkrtumyan
Publicado: (2010)

Anemia in patients with type 1 diabetes mellitus
por: Tatiana Yur'evna Kufelkina, et al.
Publicado: (2010)

Diabetes and Cancer: Risk, Challenges, Management and Outcomes
por: Rabia K. Shahid, et al.
Publicado: (2021)

The first presentation of Wolcott‐Rallison syndrome in a four‐month‐old infant with diabetic ketoacidosis (DKA) precipitating by COVID‐19: A case report
por: Elham Maleki, et al.
Publicado: (2021)

Cálculo del impacto económico para Chile del uso de losartán en diabéticos tipo 2 con nefropatía diabética, basado en resultados del estudio RENAAL
por: González F,Fernando, et al.
Publicado: (2009)

Perfil de usuarios con diabetes e hipertensión arterial y su relación con indicadores de resultado clínicos
por: Lagos,María Elena, et al.
Publicado: (2018)

The relationships between glucose variability and renal function in type 2 diabetes patients on basal-bolus insulin therapy
por: Vadim V. Klimontov, et al.
Publicado: (2015)

Resistance of CA1 Pyramidal Cells to STZ-Induced Diabetes in Young Rats
por: Fazeli,Seyyed Amirhossein, et al.
Publicado: (2009)

Comments on the Consensus statement of the American Diabetes Association and the European Association for the Studyof Diabetes on the medical management of hyperglycemia in type 2 diabetes
por: Ivan Ivanovich Dedov, et al.
Publicado: (2009)